Business Of Biotech cover image

Approvals & Mergers: Inside Enzyvant with Bill Symonds, Pharm.D.

Business Of Biotech

00:00

The Importance of Complementary Assets in Biopharma

The business of biotech brings those voices forward to help new and emerging bio farmers turn their innovations into clinical realities. The podcast is brought to you in collaboration with CITiva.com backslash emerging biotech. Tune in and subscribe for insights on hiring, regulatory and other need to know topics for biopharma leaders.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app